INNV Stock UPDATES Innovus Pharmaceuticals Inc (INNV) 0.1800

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Innovus Pharmaceuticals Inc (INNV) 0.1800 $INNV

Innovus Pharma awarded higher line of credit of USD1.5m from CEO
M2 - Thu Aug 07, 7:03AM CDT
Sexual dysfunction company Innovus Pharmaceuticals (Other OTC:INNV) reported on Wednesday a rise in its line of credit with its president and CEO, Dr Bassam Damaj, to USD1.5m.

Innovus Pharma Secures Additional Funding by Increasing Its Line of Credit With Its Chief Executive Officer to $1.5M, Provides Quarter Update and Timing of Its 10-Q Filing
GlobeNewswire - Wed Aug 06, 5:01AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCQB:INNV) today announced that the Company increased its Line of Credit with Dr. Bassam Damaj, its President & CEO to a total of $1.5M. This added funding combined with the revenues from sales of commercial products both in the US and Canada, as well as from the new international partnerships the Company expects to announce this year, the Company believes, will provide a cash runway until Q2 2015. "My strong belief in the success of the Company and its commercial pipeline makes my commitment to Innovus unwavering," said Dr. Damaj, President & Chief Executive Officer of the Company.

Innovus Pharma to Present at the FSXinterlinked Financial Investment Conference in Westlake Village, CA
GlobeNewswire - Mon Jul 28, 1:32PM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that Dr. Bassam Damaj, President & CEO of the Company will present to an audience of principals and key decision makers of broker/dealers and financial firms at the FSXinterlinked Financial Investment Conference to be held at the Four Season Westlake Village, California from July 30-August 2, 2014. The presentation will take place on Thursday, July 31, 2014 at 1:57pm.

Innovus Pharma Provides Corporate Update
ACCESSWIRE - Wed Jun 25, 5:29AM CDT
San Diego, CA / ACCESSWIRE / June 25, 2014 / Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company" (OTCBB: INNV) (http://www.innovuspharma.com/) announced today a corporate mid-year update covering Company activities, expected near-term events and comments on recent market conditions, as follows:

Innovus Pharma to Exhibit Zestra(R), Its Clinically Proven Topical Product for Sexual Arousal and Desire at the 46th Annual Meeting of the American Association of Sexuality Educators Counselors & Therapists
GlobeNewswire - Wed Jun 04, 10:17AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that it will exhibit Zestra(R), its topical over-the-counter ("OTC" product for female sexual arousal and desire, at the 46 Annual Meeting of the American Association of Sexuality Educators Counselors & Therapists ("AASECT" in Monterrey, CA. The meeting will be held from June 4-8, with exhibits from June 6-7 at the Portola Hotel and Spa. Innovus will be presenting the clinical benefits and use of Zestra(R) at its booth during the exhibition with education sessions to sexual counselors, educators and therapists throughout the meeting.

Personal Accident and Health Insurance in Greece, Key Trends and Opportunities to 2017
M2 - Wed Feb 26, 4:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/bjj4j7/personal_accident) has announced the addition of the "Personal Accident and Health Insurance in Greece, Key Trends and Opportunities to 2017" report to their offering. The Greek personal accident and health insurance segment accounted for the lowest share of premiums in the overall insurance industry in 2012. Demand for healthcare services and private health insurance increased during the review period (2008-2012), due to the inadequate service provided by public healthcare institutions and increasing per capita healthcare expenditure. Travel insurance accounted for the largest share of the segment. Growth in the category was supported by the introduction of low-cost airlines which increased the number of outbound tourists. Over the forecast period (2012-2017), the growth of the personal accident and health segment is expected to be driven by the travel and health insurance categories. Overall, the value of the Greek personal accident and health segment is expected to increase at a forecast-period compound annual growth rate (CAGR) of 5.5%. Key Topics Covered 1 Executive Summary 2 Introduction 3 Greek Insurance Industry Attractiveness 4 Personal Accident and Health Insurance Segment Outlook 5 Analysis by Distribution Channels 6 Porter's Five Forces Analysis - Greek Personal Accident and Health Insurance 7 Reinsurance Growth Dynamics and Challenges 8 Governance, Risk and Compliance 9 Competitive Landscape and Strategic Insights 10 Business Environment and Country Risk 11 Appendix Companies Mentioned - Eurolife - ING Greek Life Insurance - Metlife Alico For more information visit http://www.researchandmarkets.com/research/bj...l_accident About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Innovus Pharma reports market launch of EjectDelay in the US
M2 - Mon Feb 24, 7:02AM CST
Pharmaceuticals company Innovus Pharmaceuticals (Other OTC:INNV) disclosed on Friday the market availability of its over the counter (OTC) benzocaine-based topical premature ejaculation treatment, EjectDelay, in the US.

Innovus Pharma Announces Availability of EjectDelay(TM) for Premature Ejaculation in the United States
GlobeNewswire - Fri Feb 21, 5:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCBB:INNV) today announced the availability of its over the counter ("OTC" benzocaine-based topical premature ejaculation treatment EjectDelay(TM) in the United States ("U.S." .

Innovus Pharma to Exhibit Zestra(R) its Clinically Proven Product for Female Sexual Arousal and Desire at the International Society for the Study of Women's Sexual Health 2014 Annual Meeting in San Diego
GlobeNewswire - Thu Feb 20, 9:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTC BB:INNV) today announced that it will exhibit Zestra(R), its topical over the counter ("OTC" product for female sexual arousal and desire at the 2014 Annual International Society for the Study of Women's Sexual Health Meeting in San Diego from February 20-22, 2014.

Innovus Pharmaceuticals Inc elects Lynnette Dillen as CFO & EVP
M2 - Wed Feb 12, 4:23AM CST
Sexual dysfunction products company Innovus Pharmaceuticals Inc (Other OTC:INNV) revealed on Tuesday the appointment of Lynnette Dillen as executive vice president and chief financial officer for its finance, accounting, human resources, information technology and investor relations.

Innovus Pharma Expands Management Team and Adds Chief Financial Officer
GlobeNewswire - Tue Feb 11, 5:15AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCBB:INNV), today announced that Lynnette Dillen has joined the company as Executive Vice President and Chief Financial Officer with responsibility for finance, accounting, human resources, information technology and investor relations.

Innovus Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference in New York
GlobeNewswire - Wed Feb 05, 5:00AM CST
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company" , www.innovuspharma.com, (OTCBB:INNV) today announced that Dr. Bassam Damaj, Ph.D., Chief Executive Officer and President, will present at the 16th Annual BIO CEO & Investor Conference, to be held at the Waldorf-Astoria Hotel in New York February 10-11, 2014. Dr. Damaj is scheduled to present on Monday, February 10th at 11:00 a.m. EST in the Conrad Room. Dr. Damaj will give an overview of the Company and discuss the recent acquisition of Semprae Laboratories, Inc., the Company's growing pipeline and its projected growth. In addition, he will preview the recent accomplishments of the Company and the upcoming milestones.

TRENDnet(R) 720p Cloud Cameras Now Available
Marketwire - Tue Feb 04, 6:44AM CST
TRENDnet, a best-in-class wired and wireless networking hardware brand, today announces the availability of the HD Wireless Day / Night Cloud Camera (model TV-IP762IC) and HD Wireless Day / Night PTZ Cloud Camera (model TV-IP862IC).

Ogun APC - the Trouble That Was Foretold
by Daud Olatunji - All Africa Global Media - Wed Jan 22, 2:09AM CST
The emergence of Senator Ibikunle Amosun as the gubernatorial flag bearer of the defunct Action Congress of Nigeria, ACN in 2011 predicted trouble for the status quo. It didn't take long for it to burst.

Innovus Pharma Provides Regulatory and Commercial Update on the Label Indication for Zestra(R) for Female Sexual Desire Disorder ("FSDD" from Health Canada
GlobeNewswire - Fri Jan 10, 5:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCBB:INNV) today announced that its newly acquired wholly-owned subsidiary, Semprae Laboratories, Inc. ("Semprae" is working with Health Canada to finalize the packaging for the indication for its topical over the counter ("OTC" Natural Health Product, Zestra(R), for the temporary improved sexual desire in women suffering from female sexual desire disorder" ("FSDD" . The first Canadian Product License approval for this indication was obtained by Semprae in July 2012, but never applied to the Zestra(R) label. The Company is expected to finalize the new packaging for this product with Health Canada with the approved FSDD indication within 90 days. In addition, the Company is filing to expand the indication to women with Female Sexual Arousal Disorder (FSAD) due to statistically significant improvement in arousal and Female Sexual Function Index (FSFI) scores observed in its large clinical trial in women with FSAD.

Innovus Pharmaceuticals, Inc. Acquires Semprae Laboratories, Inc.
GlobeNewswire - Mon Dec 30, 5:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCBB:INNV) today announced that the Company acquired Semprae Laboratories, Inc. ("Semprae" through a merger and for shares of common stock of Innovus Pharma. Semprae is a New Jersey company founded by women in 2008 with the goal of improving women's sexual lives. From the beginning, Semprae has been marketing Zestra(TM), the first non-prescription product clinically proven to increase arousal, sensation, pleasure and satisfaction in women. In 2011, Semprae introduced Zestra Glide(TM), an accompanying water based lubricant. Together the two products had gross sales of approximately $1 million in 2013.

Innovus Pharma Announces Start of Its CIRCUMserum(TM) Commercial Phase in Morocco With Initial Order of 10,000 Units by Its Partner Ovation Pharma
GlobeNewswire - Fri Dec 27, 5:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCBB:INNV) announced today that its topical treatment for reduced penile sensitivity, CIRCUMserum(TM), has received importation and commercialization approval from the Moroccan Ministry of Health. In addition, the Company announced that its partner Ovation Pharma SARL ("Ovation Pharma" placed its first order for 10,000 units of CIRCUMserum(TM) and provided the Company with a partial payment for the order. Innovus expects to deliver the units in Q1 2014 in time for Ovation Pharma's official launch of the product in Morocco at that time. The Company and Ovation Pharma entered into a license and distribution agreement (the "License Agreement" under which Innovus Pharma granted to Ovation Pharma an exclusive license to market and sell Innovus Pharma's CIRCUMserum(TM) in Morocco. Pursuant to the License Agreement, Ovation Pharma may pay Innovus Pharma up to approximately $11.25 million for the achievement of certain commercial milestones described therein.

Innovus Pharma Expands Management Team and Adds Acting General Counsel and Vice President of Finance
GlobeNewswire - Thu Sep 19, 5:30AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCBB:INNV) today announced that Randy Berholtz was appointed as Acting General Counsel of the Company, an expansion to his previously appointed position as Secretary, and Lynnette Dillen has joined the Company as Vice President of Finance. Ms. Dillen will be responsible for administrative, financial, and risk management of the company.

Lipocine Inc. Appoints Morgan Brown as Executive Vice President and Chief Financial Officer
Business Wire - Mon Sep 16, 7:00AM CDT
Lipocine Inc. ("Lipocine" (OTCQB/OTCBB: LPCN), a specialty pharmaceutical company, announced today that Morgan Brown has joined the Company as Executive Vice President and Chief Financial Officer ("CFO" . Mr. Brown has more than 20 years of financial and accounting experience, including over 13 years in financial management of life science companies.

Innovus Pharmaceuticals Inc enters into second license and distribution agreement for EjectDelay in Morocco
M2 - Wed Sep 11, 9:53AM CDT
Pharmaceutical company Innovus Pharmaceuticals Inc (OTC Markets:INNV) reported on Wednesday the launch of a second license and distribution agreement to grant an exclusive license to market and sell its topical premature ejaculation treatment, EjectDelay, in Morocco.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 81

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 92

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading
AI Shopping Answers Are Becoming Retail's New Shelf

Updated Category News Views 67

Retail’s front door is quietly being moved by a machine, and plenty of big chains appear to be staring at the old entrance. Bain’s latest work lands on an uncomfortable point: owning market share does not guarantee a retailer gets named when an AI assistant answers a shopper’s question. That ought to rattle management teams more than the usual holiday-season...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 25

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 74

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
Why Insurance Must Change as Family Assets Keep Growing

Updated Category News Views 32

A policy bought in the starter-home years can turn stale quietly while everything around it gets bigger, pricier and more complicated. That is the uncomfortable little truth behind Daniel C. DiCocco's discussion in HelloNation: families often treat insurance as a box checked long ago, even as they add property, savings, debt, children and fresh responsibilities. Static...

Continue Reading
Childcare Scale Makes Its Case, With Caveats Attached

Updated Category News Views 58

Childcare’s math is brutal before anybody starts arguing over ownership. Families need dependable hours, educators deserve better pay, and operators must keep buildings safe, staffed and open without pricing working parents clean out of the market. That is why this new Tyton Partners review of multi-site providers deserves a fair look, even if nobody should mistake a...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading

Top 5 Most Recently Viewed Articles

Psyence Biomed Expands Reach with Strategic Stake Acquisition

Updated Category News Views 68

Psyence Biomed Expands its Reach with a Strategic Stake Acquisition Psyence Biomedical Ltd. (NASDAQ: PBM) is making a significant move to push forward in the field of psychedelic-based therapeutics. The company recently announced a key conditional share sale agreement to acquire an 11.13% stake in PsyLabs, an important player in producing psychedelic active pharmaceutical...

Continue Reading
Market Movements: Analysis of Recent IREN Options Activity

Updated Category News Views 219

Market Movements: Insightful Look into IREN Options Activity Recent trends indicate an encouraging outlook for IREN (NASDAQ: IREN), as substantial financial entities have taken noticeable bullish positions in the options market. A detailed analysis of options trading history showcases that a staggering 43 unusual transactions have been identified. Trader Sentiment...

Continue Reading
Chery Unveils Transformable Multi-SUV at Global Brand Night

Updated Category News Views 227

Chery's Innovative Brand Night Event Chery recently held an exciting event, themed "Co-Create the New Move," which showcased its commitment to blending user innovation into automotive design. The brand night welcomed attendees from various backgrounds, including media professionals and users from around the globe. The night focused on celebrating collaboration and...

Continue Reading
STRATTEC Security Corporation's Impressive Q1 Results Revealed

Updated Category News Views 76

STRATTEC SECURITY CORPORATION Reports Fiscal Year 2025 First Quarter Financial Results STRATTEC SECURITY CORPORATION (NASDAQ: STRT) is recognized as a pioneering provider of smart vehicle access, security, and authorization solutions for the automotive landscape. The company has just shared its financial results for the first quarter of the fiscal year 2025, marking the...

Continue Reading
Dodge Unveils Exciting 2026 Muscle Car Lineup at Event

Updated Category News Views 234

Dodge Unveils Exciting 2026 Muscle Car Lineup at Event Dodge is revving up for an unforgettable experience as it showcases its 2026 muscle car lineup during a prominent automotive event. This highly awaited lineup includes powerful models like the Charger Scat Pack and the Durango SRT Hellcat Jailbreak. The event promises to attract enthusiasts and automotive fans alike,...

Continue Reading